STOCK TITAN

BlackRock ESG Capital Allocation Term Stock Price, News & Analysis

ECAT NYSE

Welcome to our dedicated page for BlackRock ESG Capital Allocation Term news (Ticker: ECAT), a resource for investors and traders seeking the latest updates and insights on BlackRock ESG Capital Allocation Term stock.

BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) is a non-diversified, closed-end management investment company advised by BlackRock Advisors, LLC. News related to ECAT often centers on its role as a listed closed-end fund in the asset management sector, its ESG capital allocation focus, and its governance and shareholder dynamics.

Coverage of ECAT includes detailed updates on proxy contests and recommendations from independent proxy advisory firms. Institutional Shareholder Services (ISS), Glass Lewis, and Egan-Jones have issued reports addressing how shareholders might vote on the fund’s WHITE proxy card in connection with the election of incumbent trustees and a proposal by a dissident shareholder to terminate BlackRock as investment adviser. These reports and related press releases provide insight into how external advisory firms assess ECAT’s performance and governance structure.

Another key stream of news involves legal proceedings brought by Saba Capital Management, L.P. concerning ECAT’s voting bylaws. Court rulings described in public releases discuss allegations that the fund’s voting standards could, under certain conditions, affect shareholders’ rights to elect trustees under the Investment Company Act. These developments are important for investors following regulatory and governance issues affecting closed-end funds.

ECAT news flow also covers capital actions such as issuer tender offers. Announcements have described oversubscribed tender offers for a portion of the fund’s outstanding common shares, including information on the percentage of shares offered, the oversubscription, and the framework for determining the purchase price relative to net asset value.

Investors and observers can use the ECAT news page to review these proxy-related developments, litigation updates, and tender offer announcements in one place, helping them follow how governance, advisory relationships, and capital management decisions evolve over time for this BlackRock-advised closed-end fund.

Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) urges shareholders to return the WHITE voting instruction form to elect Board nominees ahead of the annual meeting on June 9, 2026. The Board highlights an 86% cumulative market-price return since January 2023, $982 million distributed since inception, a 233% increase in distributions since inception, and over $100 million in share repurchases.

The release warns that not voting risks changes to the fund's leadership and monthly payout, and notes a contested election with an activist seeking board replacements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
-
Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) announced the certified results of its 2025 Annual Meeting of Shareholders. The meeting resulted in two key outcomes: all ten incumbent trustees were re-elected to the Board, and shareholders rejected a proposal to terminate BlackRock as the Fund's investment adviser.

Board Chair R. Glenn Hubbard expressed gratitude for shareholder support, highlighting the Fund's strong performance and consistent distributions record. The re-elected trustees include Cynthia L. Egan, Lorenzo A. Flores, Stayce D. Harris, Catherine A. Lynch, R. Glenn Hubbard, W. Carl Kester, John M. Perlowski, Robert Fairbairn, J. Phillip Holloman, and Arthur P. Steinmetz.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
none
-
Rhea-AI Summary
BlackRock announced that Egan-Jones has become the third leading proxy advisory firm, alongside ISS and Glass Lewis, to recommend ECAT shareholders vote in favor of all ten incumbent Board nominees and against Saba Capital's proposal to terminate BlackRock as investment adviser. The recommendations come ahead of BlackRock ESG Allocation Term Trust's annual meeting on June 26, 2025. Egan-Jones highlighted ECAT's superior shareholder returns compared to peers and emphasized that terminating BlackRock's investment management agreement would be detrimental to the Fund's future. The firm rejected Saba's full slate of eight nominees, stating that the dissident has not made a compelling case for termination.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
none
Rhea-AI Summary
ISS, a leading proxy advisory firm, has recommended BlackRock ESG Allocation Term Trust (ECAT) shareholders vote on the WHITE card in favor of nine out of ten incumbent Board nominees and against a dissident shareholder's proposal to terminate BlackRock as investment adviser. ISS joins Glass Lewis in rejecting the dissident's full slate of eight nominees ahead of the June 26, 2025 annual meeting. ISS highlighted that the dissident hasn't presented a compelling case for change, noting ECAT's outperformance since inception and the board's positive impact on reducing the discount since the 2024 AGM. Glass Lewis has recommended shareholders vote FOR all Board nominees and AGAINST the termination proposal on the WHITE proxy card.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
Rhea-AI Summary

BlackRock closed-end funds MVF, ECAT, and BIGZ have announced the final results of their tender offers for up to 2.5% of outstanding common shares. All offers were oversubscribed, leading to pro-rata purchases. Key details:

- MVF: 26,471,815 shares tendered, 1,586,158 to be purchased at $7.9086 per share
- ECAT: 17,487,970 shares tendered, 2,547,328 to be purchased at $18.0516 per share
- BIGZ: 42,424,300 shares tendered, 5,610,470 to be purchased at $8.1242 per share

Purchase prices are set at 98% of each fund's NAV as of August 22, 2024. Payments are expected within five business days after the expiration date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
-
Rhea-AI Summary

BlackRock closed-end funds MVF, ECAT, and BIGZ have announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 22, 2024, and ended on August 21, 2024, were significantly oversubscribed. For example, BlackRock MuniVest Fund (MVF) offered 1,586,158 shares but received tenders for 26,471,815 shares. Due to oversubscription, share purchases are expected to be prorated. The purchase price will be 98% of each fund's NAV as of August 22, 2024. Final results, including pro-ration factors, are expected to be announced around August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
none
Rhea-AI Summary

The U.S. District Court for the Southern District of New York denied BlackRock's motion to dismiss Saba Capital's lawsuit concerning the ECAT's voting bylaws. The court concluded that Saba adequately alleged that ECAT's bylaws could deprive shareholders of their right to elect trustees, violating the Investment Company Act (ICA). Judge Margaret M. Garnett found that BlackRock’s belief that ECAT could have ongoing failed elections was implausible. She emphasized that the fund's bylaws were designed to circumvent shareholder rights. The ruling also dismissed BlackRock's claims that Saba was merely an activist investor, affirming Saba's rights as a shareholder. The decision enables Saba to proceed to trial to contest ECAT’s governance practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
conferences

FAQ

What is the current stock price of BlackRock ESG Capital Allocation Term (ECAT)?

The current stock price of BlackRock ESG Capital Allocation Term (ECAT) is $13.85 as of April 3, 2026.

What is the market cap of BlackRock ESG Capital Allocation Term (ECAT)?

The market cap of BlackRock ESG Capital Allocation Term (ECAT) is approximately 1.4B.

ECAT Rankings

ECAT Stock Data

1.38B
99.35M
Asset Management
Financial Services
Link
United States
New York

ECAT RSS Feed